Third Pole Therapeutics
Bill Athenson has a diverse work experience spanning over three decades. Bill currently serves as the Chief Executive Officer at Third Pole Therapeutics, where they lead the development of transformative cardio-pulmonary therapies. Prior to this, they worked as the CEO and COO at Three Lakes Partners, where they focused on healthcare initiatives and operations. Before that, Bill was a Principal at Executive Consulting Services, where they specialized in commercial strategies for new technology platforms. Bill also held various leadership roles at Nanosphere Inc., Vianeta Communications, POCKETCARD, Cardinal Health, and Baxter International Inc., where they gained extensive experience in sales, marketing, business development, and general management.
Bill Athenson attended Northwestern University - Kellogg School of Management from 1989 to 1991, where they earned a Master of Business Administration (M.B.A.) in Marketing and Finance.
This person is not in any offices
Third Pole Therapeutics
Third Pole, Inc. is a US-based company developing next generation life-saving cardiopulmonary therapies. We are building on our team’s legacy in inhaled nitric oxide (NO), the current standard of care, to develop next generation life-saving heart and lung therapies. Our first product is being designed to be a simple, convenient, economical, and lightweight device capable of generating nitric oxide from air on-demand and on-site which potentially eliminates the need for large compressed gas cylinders. We believe our novel approach of creating NO on demand has the promise to create new markets by enabling the worldwide use of inhaled NO in settings outside of acute care.